Project Details
Description
A Phase I Trial of CC-4047 in Combination with Liposomal Doxorubicin for the Treatment of Recurrent Epithelial Ovarian Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 3/15/07 → 3/31/14 |
Funding
- CELGENE CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.